The long-term objective of this project is to understand how insulin regulates the effects of amphetamine (AMPH) that are related to its abuse. Drug abuse remains a significant public health issue with important economic and social ramifications. With regard to AMPH, development of pharmacotherapies is limited by a severe lack of information on how AMPH works at the molecular level. Dopamine (DA) transporters (DATs) largely control DA clearance from the synapse and are one important site of action for psychostimulants such as cocaine and AMPH. AMPH attenuates DA clearance efficiency by acting on DAT, thereby increasing synaptic DA levels and enhancing DA transmission. This is believed to be a primary effect contributing to AMPH abuse. Very little is known about the molecular mechanisms by which AMPH regulates DAT activity and how that regulation translates to reinforcing effects. This project will combine biochemistry, confocal microscopy and behavior to elucidate the mechanisms involved in the insulin regulation of: a) AMPH-induced DAT cell surface redistribution, and b) self administration of AMPH. The key issues that will be addressed include how insulin regulates DAT trafficking and whether AMPH causes DAT cell surface redistribution, by interfering with the insulin signaling cascade. The trafficking process affects DAT-mediated DA reuptake, ultimately regulating extracellular concentrations of DA that contribute to behavioral actions. Therefore, behavioral studies of AMPH self administration will be conducted in rats made diabetic by pharmacologic means in order to test the hypothesis that the reinforcing effects of AMPH are regulated by insulin. Our experimental plan links trafficking of the DAT to the abuse-related behavioral effects of AMPH. The proposed studies address the following Specific Aims: 1) characterize the acute insulin regulation of DA transport; 2) determine whether chronic depletion of insulin regulates DA uptake in rat striatum; and 3) assess whether chronic depletion of insulin selectively modifies the reinforcing effects of AMPH. This proposal seeks to identify molecular mechanisms for AMPH that should provide new cellular targets for substance abuse therapies.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZDA1-MXG-S (01))
Program Officer
Pilotte, Nancy S
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Vanderbilt University Medical Center
Schools of Medicine
United States
Zip Code
Sakrikar, Dhananjay; Mazei-Robison, Michelle S; Mergy, Marc A et al. (2012) Attention deficit/hyperactivity disorder-derived coding variation in the dopamine transporter disrupts microdomain targeting and trafficking regulation. J Neurosci 32:5385-97
Baladi, Michelle G; Daws, Lynette C; France, Charles P (2012) You are what you eat: influence of type and amount of food consumed on central dopamine systems and the behavioral effects of direct- and indirect-acting dopamine receptor agonists. Neuropharmacology 63:76-86
Owens, W Anthony; Williams, Jason M; Saunders, Christine et al. (2012) Rescue of dopamine transporter function in hypoinsulinemic rats by a D2 receptor-ERK-dependent mechanism. J Neurosci 32:2637-47
Niswender, Kevin D; Daws, Lynette C; Avison, Malcolm J et al. (2011) Insulin regulation of monoamine signaling: pathway to obesity. Neuropsychopharmacology 36:359-60
Speed, Nicole; Saunders, Christine; Davis, Adeola R et al. (2011) Impaired striatal Akt signaling disrupts dopamine homeostasis and increases feeding. PLoS One 6:e25169
Daws, Lynette C; Avison, Malcolm J; Robertson, Sabrina D et al. (2011) Insulin signaling and addiction. Neuropharmacology 61:1123-8
Robertson, Sabrina D; Matthies, Heinrich J G; Owens, W Anthony et al. (2010) Insulin reveals Akt signaling as a novel regulator of norepinephrine transporter trafficking and norepinephrine homeostasis. J Neurosci 30:11305-16
Speed, Nicole K; Matthies, Heinrich J G; Kennedy, J Phillip et al. (2010) Akt-dependent and isoform-specific regulation of dopamine transporter cell surface expression. ACS Chem Neurosci 1:476-81
Siuta, Michael A; Robertson, Sabrina D; Kocalis, Heidi et al. (2010) Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice. PLoS Biol 8:e1000393
Guptaroy, Bipasha; Zhang, Minjia; Bowton, Erica et al. (2009) A juxtamembrane mutation in the N terminus of the dopamine transporter induces preference for an inward-facing conformation. Mol Pharmacol 75:514-24

Showing the most recent 10 out of 32 publications